Showing results (151-160 of 170) with videos related to
Sort By:
Pageof 17
Cancer|January 1, 1986
A phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effectsR S Witte, B Pruitt, D C Tormey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Phase II study of goserelin for patients with postmenopausal metastatic breast cancerT Saphner, A B Troxel, D C Tormey, et al.Human Pathology|September 1, 1992
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancerD C Allred, G M Clark, R Molina, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology GroupP D Bonomi, D M Finkelstein, J C Ruckdeschel, et al.Cancer Research|October 1, 1988
Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvageJ K Willson, P H Fischer, K Tutsch, et al.International Journal of Radiation Oncology, Biology, Physics|October 27, 1998
Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology GroupT J Smith, L M Ryan, H O Douglass, et al.Breast Cancer Research and Treatment|October 1, 1993
High DNA content and prognosis in lymph node positive breast cancer. A case control study by the University of Leiden and ECOG. (Eastern Cooperative Oncology Group)K W Gilchrist, R Gray, A M van Driel-Kulker, et al.Cancer|January 15, 1994
Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifenK E Gale, J W Andersen, D C Tormey, et al.American Journal of Clinical Oncology|June 1, 1984
A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B studyD C Tormey, V E Weinberg, L A Leone, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinomaD C Allred, G M Clark, A K Tandon, et al.Pageof 17